D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
MRTX holding history
Mirati Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRTX overviewAll 13F holders of MRTXFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −7,693−100.0% | Sold out | Holders |
| Q4 2023 | 7,693 | $452.0K | <0.1% | −131,920−94.5% | Reduced | Holders |
| Q3 2023 | 139,613 | $6.08M | <0.1% | −123,325−46.9% | Reduced | Holders |
| Q2 2023 | 262,938 | $9.50M | <0.1% | +17,352+7.1% | Added | Holders |
| Q1 2023 | 245,586 | $9.13M | <0.1% | +32,285+15.1% | Added | Holders |
| Q4 2022 | 213,301 | $9.66M | <0.1% | −353,129−62.3% | Reduced | Holders |
| Q3 2022 | 566,430 | $39.6M | 0.1% | +249,522+78.7% | Added | Holders |
| Q2 2022 | 316,908 | $21.3M | <0.1% | +316,908 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −2,716−100.0% | Sold out | Holders |
| Q4 2021 | 2,716 | $398.0K | <0.1% | −9,592−77.9% | Reduced | Holders |
| Q3 2021 | 12,308 | $2.18M | <0.1% | −105,339−89.5% | Reduced | Holders |
| Q2 2021 | 117,647 | $19.0M | <0.1% | +35,725+43.6% | Added | Holders |
| Q1 2021 | 81,922 | $14.0M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.